Sage Therapeutics Investor Relations Material
Latest events
Q1 2025
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system (CNS) disorders. Its research targets psychiatric, neurological, and neurodevelopmental conditions. The company operates across the drug discovery, clinical development, and commercialization stages, aiming to address unmet medical needs in brain health. Sage Therapeutics Inc is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
SAGE
Country
🇺🇸 United States